Market Approval
Market Approval is mandatory at various milestones in the development of your novel biomedical intervention and need to be passed to move your product to the market and beyond.
Subscribe now or read more about this module below
Signup for 12 Nov 2024
Download the Market Approval brochure
Download brochure
Market Approval Online
Want to have a look at the way we teach online?
Identify the essential characteristics (claims) of a product
Translate these claims to a product profile and design a market approval strategy
Optimize the market approval process with information from authorities and competitors
Effectuate authority advice meetings
Use market approval to optimize product value
Learn more below or sign-up for this course directly
Apply regulatory guidelines
Through the course I learned how to find and apply regulatory guidelines to evaluate nonclinical, clinical and quality drug data, which will help in my role as hospital pharmacist/clinical pharmacist in the review committee and as clinical pharmacological researcher.
Imke Bartelink, Hospital pharmacist/ clinical pharmacologist
Very relevant contemporary cases
The online Market Approval course is a very interesting and useful course, I enjoyed it a lot! Especially the relevant and contemporary cases really were of additional value.
Anna van Muyden, Director clinical development, CellPoint
We understand if you want to have a look at this course. Login or create an account to access a free demo of the online course.
A confirmation email will be sent to new registrations. After completion, you're able to acces the online demo.
Market approval is mandatory at various milestones in the development of your novel biomedical intervention and need to be passed to move your product to the market and beyond. The program focuses on how to guide your biomedical intervention along the milestones of its life cycle in an efficient and timely manner.
What makes this course special?
The course introduces biomedical professionals to the world of authorities and regulatory affairs. It is interesting for anyone who aims to bring a new medical intervention to market now or in the future. You will learn to identify the product claims that require market approval and how to define a strategy to obtain market approval alongside the developmental program of your product. We will address the authority landscape (e.g. EMA, FDA, Notified bodies, EFSA), legislation, regulatory dossiers, authority advice meetings, product labels and approaches for device-drug combinations and other novel/complex products that require a tailored market approval approach. To deepen your acquired skills, scenarios based on real-world cases are included in exercises to illustrate the complexity and dynamics involved in obtaining and maintaining market approval of biomedical interventions.
What will you learn?
In this 5-week online course, you are introduced to the world of authorities and regulatory affairs for novel medical interventions – medicinal products, medical devices and medical nutrition. You will learn to identify the product claims that require approval and the way to structure an approach towards
5 things you will take away from this course
- Identify the essential characteristics (claims) of a product.
- translate these claims to a product profile and design a market approval strategy.
- optimize the market approval process with information from authorities and competitors.
- effectuate authority advice meetings.
- use market approval to optimize product value.
Accredited
The Market Approval course is accredited (38 hours) by the Dutch Association of Hospital Pharmacists (NVZA).
I know enough, let's
Market Approval contributors
Juliane Bernholz
Chief Operating Officer
AM Pharma
Onno van de Stolpe
Former CEO
Galapagos
Bert Leufkens
Professor of Pharmaceutical Policy and Regulatory Science and Former Chair of Medicines Evaluation Board
Utrecht Institute for Pharmaceutical Sciences (UIPS)
Henk Schuring
VP-Head Rare Nephrology
Prilenia
Sjaak Bot
Former VP, Head of EMEA Regulatory Affairs
Janssen
Bernd van der Meulen
Professor of Comparative Food Law
European Institute for Food Law / Renmin University of China Law School
Eline Bunnik
Assistant professor Medical Ethics and Philosophy of Medicine
Erasmus MC
On-campus
Ineke Jonker-Hoogerkamp
Consultant Regulatory Affairs and Drug Development
Paul Janssen Futurelab & Eagle Pharma Consult